April 2020 – VYNE Therapeutics

SEC Filing: Form 8-K

April, 23 2020

Current report

Post date April 23, 2020

SEC Filing: Form SC 13D/A

April, 16 2020

General statement of acquisition of beneficial ownership – amendment

Post date April 16, 2020

SEC Filing: Form 8-K

April, 10 2020

Current report

Post date April 10, 2020

SEC Filing: Form 8-K

April, 06 2020

Current report

Post date April 6, 2020

Nothing left to load.